• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

继发性噬血细胞性淋巴组织细胞增生症胸腔积液的特征和预后价值。

Characteristics and prognostic value of pleural effusion in secondary hemophagocytic lymphohistiocytosis.

机构信息

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, 300 Guangzhou Road, Nanjing, 210029, China.

Department of Geriatric Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, 300 Guangzhou Road, Nanjing, 210029, China.

出版信息

Int J Hematol. 2022 Jul;116(1):102-109. doi: 10.1007/s12185-022-03333-9. Epub 2022 Mar 25.

DOI:10.1007/s12185-022-03333-9
PMID:35338447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8956144/
Abstract

The clinical features of patients with secondary hemophagocytic lymphohistiocytosis (sHLH) complicated with pleural effusion have rarely been evaluated. We retrospectively analyzed 203 patients newly diagnosed with sHLH from July 2015 to July 2019 according to the HLH-2004 protocol. Baseline characteristics, laboratory results, and imaging were reviewed. Pleural effusion was found in 58.6% of the studied sHLH population, and characteristic imaging findings were minimal volume and bilaterality. Patients with pleural effusion had lower PLT counts, HB levels and ALB levels as well as higher sCD25 levels than those without pleural effusion (all p values < 0.05). Multivariate analyses showed that lg(sCD25) and PLT ≤ 65 × 10/L were significant risk factors for developing pleural effusion in sHLH. Regarding prognostic value, survival analysis showed a lower survival probability for patients with pleural effusion than for those without pleural effusion (median OS, 90 vs. 164 days, p = 0.028). In multivariate analysis, pleural effusion was an independent prognostic factor for overall survival (OS) (HR 2.68; 95% CI 1.18-6.11, p = 0.019). Pleural effusion is frequently found in patients with sHLH and is associated with greater inflammation and worse outcomes.

摘要

继发性噬血细胞性淋巴组织细胞增生症(sHLH)合并胸腔积液患者的临床特征很少被评估。我们回顾性分析了 2015 年 7 月至 2019 年 7 月期间根据 HLH-2004 方案新诊断的 203 例 sHLH 患者。回顾了基线特征、实验室结果和影像学表现。研究人群中 58.6%的 sHLH 患者发现胸腔积液,特征性影像学表现为少量胸腔积液且双侧性。胸腔积液患者的血小板计数、HB 水平和 ALB 水平较低,sCD25 水平较高(均 p 值<0.05)。多变量分析表明,lg(sCD25)和血小板计数≤65×10/L 是 sHLH 发生胸腔积液的显著危险因素。关于预后价值,生存分析显示胸腔积液患者的生存率低于无胸腔积液患者(中位 OS,90 天 vs. 164 天,p=0.028)。多变量分析显示,胸腔积液是总生存(OS)的独立预后因素(HR 2.68;95%CI 1.18-6.11,p=0.019)。胸腔积液在 sHLH 患者中很常见,与更严重的炎症和更差的预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/670d/8956144/6ef28712632c/12185_2022_3333_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/670d/8956144/4d9bac784ee4/12185_2022_3333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/670d/8956144/6ef28712632c/12185_2022_3333_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/670d/8956144/4d9bac784ee4/12185_2022_3333_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/670d/8956144/6ef28712632c/12185_2022_3333_Fig2_HTML.jpg

相似文献

1
Characteristics and prognostic value of pleural effusion in secondary hemophagocytic lymphohistiocytosis.继发性噬血细胞性淋巴组织细胞增生症胸腔积液的特征和预后价值。
Int J Hematol. 2022 Jul;116(1):102-109. doi: 10.1007/s12185-022-03333-9. Epub 2022 Mar 25.
2
Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis.继发性噬血细胞性淋巴组织细胞增生症早期死亡的危险因素和预后。
Ann Hematol. 2023 Sep;102(9):2301-2308. doi: 10.1007/s00277-023-05153-1. Epub 2023 Jun 2.
3
[Effect of Plasma Epstein-Barr Virus Nucleic Acid Loads on the Clinical Features and Prognosis in Adult Secondary Hemophagocytic Lymphohistiocytosis].[血浆EB病毒核酸载量对成人继发性噬血细胞性淋巴组织细胞增生症临床特征及预后的影响]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Aug;32(4):1238-1247. doi: 10.19746/j.cnki.issn.1009-2137.2024.04.041.
4
[Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].[老年重症新型冠状病毒肺炎患者继发噬血细胞性淋巴组织细胞增生症的临床特征及危险因素:一项多中心回顾性队列研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Aug;35(8):793-799. doi: 10.3760/cma.j.cn121430-20230510-00158.
5
Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis.基于血液的炎症生物标志物在继发性噬血细胞性淋巴组织细胞增生症中的预后价值。
J Clin Immunol. 2020 Jul;40(5):718-728. doi: 10.1007/s10875-020-00801-x. Epub 2020 Jun 3.
6
Low T3 syndrome is a prognostic marker of poor outcomes in secondary hemophagocytic lymphohistiocytosis.低 T3 综合征是继发性噬血细胞性淋巴组织细胞增多症不良预后的预测指标。
Leuk Lymphoma. 2020 Dec;61(12):2947-2954. doi: 10.1080/10428194.2020.1789623. Epub 2020 Jul 9.
7
Clinical features of 47 secondary hemophagocytic lymphohistiocytosis patients complicated with capillary leak syndrome.47 例继发性噬血细胞性淋巴组织细胞增生症并发毛细血管渗漏综合征患者的临床特征。
Int J Hematol. 2021 Feb;113(2):263-270. doi: 10.1007/s12185-020-03011-8. Epub 2020 Oct 9.
8
Prognosis predicting value of semiquantitative parameters of visceral adipose tissue and subcutaneous adipose tissue of F-FDG PET/CT in newly diagnosed secondary hemophagocytic lymphohistiocytosis.F-FDG PET/CT 检查中内脏和皮下脂肪组织半定量参数对新诊断的继发性噬血细胞性淋巴组织细胞增生症的预后预测价值。
Ann Nucl Med. 2021 Mar;35(3):386-396. doi: 10.1007/s12149-021-01577-9. Epub 2021 Jan 19.
9
[Analysis of High-Risk Clinical Factors of Early Death in Secondary Hemophagocytic Lymphohistiocytosis].[继发性噬血细胞性淋巴组织细胞增生症早期死亡的高危临床因素分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Dec;31(6):1866-1871. doi: 10.19746/j.cnki.issn.1009-2137.2023.06.041.
10
Comprehensive evaluation of immune dysregulation in secondary hemophagocytic lymphohistiocytosis.继发性噬血细胞性淋巴组织细胞增生症免疫失调的综合评估。
Virulence. 2024 Dec;15(1):2342276. doi: 10.1080/21505594.2024.2342276. Epub 2024 Apr 17.

引用本文的文献

1
Hemophagocytic Lymphohistiocytosis Complicating a Case of Drug-Induced Liver Injury Precipitated by Cephalexin: A Rare Consequence of Commonly Prescribed Medications.头孢氨苄引发药物性肝损伤并发噬血细胞性淋巴组织细胞增生症:常用处方药的罕见后果
Case Reports Hepatol. 2025 May 19;2025:4600879. doi: 10.1155/crhe/4600879. eCollection 2025.
2
Comprehensive evaluation of immune dysregulation in secondary hemophagocytic lymphohistiocytosis.继发性噬血细胞性淋巴组织细胞增生症免疫失调的综合评估。
Virulence. 2024 Dec;15(1):2342276. doi: 10.1080/21505594.2024.2342276. Epub 2024 Apr 17.